The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
U.S. Department of Health and Human Services
  • YouTube
  • HRSA eNews
  • Print this
  • Email this

U.S. Patient Survival Report

The U.S. Patient Survival Report displays an estimate of the number of patients who are alive after a bone marrow or umbilical cord blood transplant. The estimates are shown:

  • By disease and length of time after transplant: 100 days, 1 year, and 3 years
  • By the type of donor who provided the cells for transplant:
    • Autologous (the patient's cells)
    • Related allogeneic (a patient's sibling or another family member's cells)
    • Unrelated allogeneic (a volunteer donor's cells)

The cells used for transplant can be from bone marrow, peripheral blood, or umbilical cord blood that is collected after a baby is born.

Choose the information for your report and then click Continue.
(To change a selection, use Previous Step.)

Using This Report

To understand how this report applies to your situation, talk with your doctor.

Transplant Data for This Report
Trends and More Data

View slides of transplant and outcomes data collected by the CIBMTR and information about transplants using only unrelated donors collected by the National Marrow Donor Program® (NMDP).